Adage Capital Partners
CAMP icon

Adage Capital Partners’s CAMP4 Therapeutics CAMP Stock Holding History

Adage Capital Partners’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.65M Sell
1,960,784
-220,895
-10% -$1.05M 0.01% 719
2025
Q4 		$13.4M Buy
2,181,679
+220,895
+11% +$940K 0.02% 601
2025
Q3 		$5.88M Buy
+1,960,784
New +$3.63M 0.01% 716

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Adage Capital Partners's CAMP Position: Q1 2026 in Review

Adage Capital Partners reduced its CAMP4 Therapeutics (CAMP) stake by 10% in Q1 2026, selling an estimated $1.05M and leaving 1,960,784 shares worth $8.65M. The position accounts for 0.01% of the portfolio, ranked #719.

Adage Capital Partners first reported a position in CAMP in Q3 2025 and has held it in 3 quarters since. The position peaked at $13.4M in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Adage Capital Partners held 1,960,784 shares of CAMP4 Therapeutics worth $8.65M as of Q1 2026.
  • Adage Capital Partners sold 220,895 CAMP4 Therapeutics shares in Q1 2026, an estimated $1.05M.
  • CAMP4 Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #719 holding.
  • Adage Capital Partners first reported a position in CAMP4 Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Adage Capital Partners's CAMP4 Therapeutics position peaked at $13.4M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.